Neumora Therapeutics Inc Sustainability Reports
Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing precision medicines for neuropsychiatric disorders and neurodegenerative diseases. The company integrates data science with translational neuroscience to identify and target novel mechanisms of action for brain diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG012W9C504
1 reports from 2023 to 2023
Company Profile
Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing precision medicines for neuropsychiatric disorders and neurodegenerative diseases. The company integrates data science with translational neuroscience to identify and target novel mechanisms of action for brain diseases.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
